The 2026 Pharmaceutical Innovation Policy Forum was held in Beijing to discuss the high-quality development of the industry.

The 2026 Pharmaceutical Innovation Policy Forum was held in Beijing. The forum focused on the historical new positioning of the biopharmaceutical industry as an "emerging pillar industry" and discussed the path to transforming policy dividends into effective industrial growth. Lin Hang, Deputy District Mayor of Haidian District, Beijing, stated that in order to transform innovative resources into industrial advantages, Haidian District will make precise efforts, empower industries with AI technology, iterate and upgrade special support measures, and break through the barriers of medical insurance and specialty disease data. At the same time, the Beijing Drug Regulatory Scientific Innovation Center was established to explore the establishment of a green channel for accelerating the conversion of clinical research initiated by researchers to clinical trial applications and conditional approval, with AI empowering regulatory innovation. Looking to the future, Haidian District will accelerate the formation of industrial synergy, create a "one-stop AI reshaping pharmaceutical R&D new paradigm platform," and strive to establish a distinct "Haidian coordinate" in the global biopharmaceutical innovation landscape.